Explainable deep learning framework for cancer therapeutic target prioritization leveraging PPI centrality and node embeddings

The framework achieved high accuracy (93% AUROC) in identifying cancer drug targets by combining network analysis with explainable AI, meaning researchers can now more reliably predict which genes are essential for cancer cells to survive, potentially accelerating drug discovery.

The researchers prioritized interpretability by using GradientSHAP analysis to show exactly which features contributed to each prediction, addressing a key responsible AI concern: users can understand why the model recommended specific genes as targets rather than treating it as a "black box."

Network position matters: genes with high "degree centrality" (many connections to other proteins) showed the strongest correlation with essentiality, suggesting that targeting hub proteins in cancer cell networks could be more effective—a finding that's actionable for drug developers.

The model successfully identified known cancer-critical genes (like MYC and ribosomal proteins) that were already validated in experiments, demonstrating the framework's reliability and suggesting it could confidently guide researchers toward novel therapeutic targets they haven't yet discovered.

By combining multiple analytical approaches (centrality metrics, embeddings, and probability scores), the framework reduced bias from any single method, reflecting responsible AI practice of using diverse evidence rather than relying on one potentially flawed approach.